PainReform Overview
- Year Founded
-
2007
- Status
-
Public
- Employees
-
7
- Stock Symbol
-
PRFX
- Share Price
-
$0.58
- (As of Friday Closing)
PainReform General Information
Description
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
Contact Information
Website
www.painreform.comCorporate Office
- 65 Yigal Alon Street
- Po Box 68
- Tel Aviv 6744316
- Israel
Corporate Office
- 65 Yigal Alon Street
- Po Box 68
- Tel Aviv 6744316
- Israel
PainReform Timeline
PainReform Stock Performance
As of 08-Nov-2024, PainReform’s stock price is $0.58. Its current market cap is $1.3M with 2.23M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.58 | $0.60 | $0.43 - $20.16 | $1.3M | 2.23M | 492K | -$36.84 |
PainReform Financials Summary
As of 30-Jun-2024, PainReform has a trailing 12-month revenue of null.
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | (2,629) | (4,201) | (8,567) | (4,396) |
Revenue | 0 | 0 | 0 | 0 |
EBITDA | (17,962) | (9,727) | (8,928) | (7,233) |
Net Income | (17,673) | (9,344) | (8,792) | (7,246) |
Total Assets | 3,107 | 9,930 | 12,328 | 19,073 |
Total Debt | 59 | 86 | 0 | 0 |
PainReform Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
PainReform Comparisons
Industry
Financing
Details
PainReform Competitors (2)
One of PainReform’s 2 competitors is Pacira BioSciences, a Formerly VC-backed company based in Tampa, FL.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Pacira BioSciences | Formerly VC-backed | Tampa, FL | ||||
Durect | Formerly VC-backed | Cupertino, CA |
PainReform Patents
PainReform Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20150148325-A1 | Depot formulations of a hydrophobic active ingredient and methods for preparation thereof | Active | 10-May-2012 | ||
US-20150111923-A1 | Depot formulations of a local anesthetic and methods for preparation thereof | Active | 10-May-2012 | ||
US-9849088-B2 | Depot formulations of a hydrophobic active ingredient and methods for preparation thereof | Active | 10-May-2012 | ||
US-9668974-B2 | Depot formulations of a local anesthetic and methods for preparation thereof | Active | 10-May-2012 | ||
US-20180049985-A1 | Depot formulations of a local anesthetic and methods for preparation thereof | Active | 10-May-2012 | A61K9/1277 |
PainReform Signals
PainReform FAQs
-
When was PainReform founded?
PainReform was founded in 2007.
-
Where is PainReform headquartered?
PainReform is headquartered in Tel Aviv, Israel.
-
What is the size of PainReform?
PainReform has 7 total employees.
-
What industry is PainReform in?
PainReform’s primary industry is Drug Discovery.
-
Is PainReform a private or public company?
PainReform is a Public company.
-
What is PainReform’s stock symbol?
The ticker symbol for PainReform is PRFX.
-
What is the current stock price of PainReform?
As of 08-Nov-2024 the stock price of PainReform is $0.58.
-
What is the current market cap of PainReform?
The current market capitalization of PainReform is $1.3M.
-
Who are PainReform’s competitors?
Pacira BioSciences and Durect are competitors of PainReform.
-
What is PainReform’s annual earnings per share (EPS)?
PainReform’s EPS for 12 months was -$36.84.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »